Celcuity Inc News Today

MINNEAPOLIS, June 03, 2024 -- Celcuity Inc. , a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced its participation in the Jefferies...

HC Wainwright reissued their buy rating on shares of Celcuity (NASDAQ:CELC – Free Report) in a report released on Thursday morning, Benzinga reports. They currently have a $27.00 price objective on the stock. HC Wainwright also issued estimates for Celcuity’s FY2028 earnings at $4.08 EPS. A number of other analysts also recently weighed in on […]

Craig Hallum reissued their buy rating on shares of Celcuity (NASDAQ:CELC – Free Report) in a research note issued to investors on Thursday, Marketbeat.com reports. The firm currently has a $27.00 target price on the stock, up from their previous target price of $25.00. Several other research firms have also commented on CELC. Needham & […]

Stifel Nicolaus reissued their buy rating on shares of Celcuity (NASDAQ:CELC – Free Report) in a report published on Thursday morning, Benzinga reports. They currently have a $40.00 price objective on the stock. A number of other research firms have also issued reports on CELC. Needham & Company LLC reissued a buy rating and set […]

Celcuity (NASDAQ:CELC – Get Free Report)‘s stock had its “buy” rating reiterated by equities research analysts at Needham & Company LLC in a report issued on Thursday, Benzinga reports. They presently have a $24.00 price target on the stock. Needham & Company LLC’s target price points to a potential upside of 39.29% from the stock’s […]

Operator: Good afternoon, ladies and gentlemen. And welcome the Celcuity First Quarter 2024 Financial Results Conference call. At this time, all lines are in a listen-only mode.

Celcuity (NASDAQ:CELC – Get Free Report)‘s stock had its “buy” rating reaffirmed by investment analysts at Craig Hallum in a report issued on Thursday, Benzinga reports. They presently have a $27.00 price objective on the stock, up from their previous price objective of $25.00. Craig Hallum’s price target points to a potential upside of 51.09% […]

Celcuity Inc. (NASDAQ:CELC – Get Free Report) shares gapped up prior to trading on Thursday . The stock had previously closed at $17.23, but opened at $19.47. Celcuity shares last traded at $18.20, with a volume of 46,888 shares traded. Analyst Ratings Changes CELC has been the subject of a number of recent research reports. […]

USA News Group – According to a “highly troubling” new study, the rising number of cancer cases in young people is being attributed to “accelerated aging.” Further alarm is being spread by the United Nations, whose health ...

/PRNewswire/ -- According to a "highly troubling" new study, the rising number of cancer cases in young people is being attributed to "accelerated aging."...